Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis

K. Kubova, D. Peček, K. Hasserová, P. Doležel, M. Pavelková, J. Vyslouzil, J. Muselík, D. Vetchy,

. 2017 ; 22 (2) : 206-217. [pub] 20170106

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013314

Hypromellose matrices exhibit extended burst effect immediately after contact with aqueous medium, especially when a water-soluble drug is incorporated. The objective of this study was to reduce burst effect and maintain complete dissolution of a very soluble levetiracetam over 12 h period from hypromellose K4M matrices to obtain zero-order kinetics. Desired changes were achieved by applying water dispersions of insoluble Eudragits(®) (NE, NM, RL, RS) as a granulation liquid to the drug/microcrystalline cellulose mixture during high-shear granulation (non-thermal treated set) and consequently by thermally treating granules or final tablets (TT), respectively. Applying Eudragit(®) water dispersions to the drug/microcrystalline cellulose mixture was recognized as an effective method of significantly reducing the burst release (25.4-33.7%) of levetiracetam in comparison with a reference sample without Eudragit(®). Multivariate data analysis showed that the addition of Eudragit(®) reduced burst effect, increased fitting with zero-order kinetics, and supported matrix erosion as the supplementary mechanism to predominant diffusion. Moreover, resulting PCA sub-model revealed the addition of Eudragit(®) RL and thermal treatment of tablets to be the most suitable method of all. For a 12 h dissolution profile, characterized by low burst effect and drug release close to 100% at the 12th hour, sample RL_TT was the most suitable.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013314
003      
CZ-PrNML
005      
20170427100140.0
007      
ta
008      
170413s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/10837450.2016.1193191 $2 doi
035    __
$a (PubMed)28058866
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kubova, Katerina $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
245    14
$a The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis / $c K. Kubova, D. Peček, K. Hasserová, P. Doležel, M. Pavelková, J. Vyslouzil, J. Muselík, D. Vetchy,
520    9_
$a Hypromellose matrices exhibit extended burst effect immediately after contact with aqueous medium, especially when a water-soluble drug is incorporated. The objective of this study was to reduce burst effect and maintain complete dissolution of a very soluble levetiracetam over 12 h period from hypromellose K4M matrices to obtain zero-order kinetics. Desired changes were achieved by applying water dispersions of insoluble Eudragits(®) (NE, NM, RL, RS) as a granulation liquid to the drug/microcrystalline cellulose mixture during high-shear granulation (non-thermal treated set) and consequently by thermally treating granules or final tablets (TT), respectively. Applying Eudragit(®) water dispersions to the drug/microcrystalline cellulose mixture was recognized as an effective method of significantly reducing the burst release (25.4-33.7%) of levetiracetam in comparison with a reference sample without Eudragit(®). Multivariate data analysis showed that the addition of Eudragit(®) reduced burst effect, increased fitting with zero-order kinetics, and supported matrix erosion as the supplementary mechanism to predominant diffusion. Moreover, resulting PCA sub-model revealed the addition of Eudragit(®) RL and thermal treatment of tablets to be the most suitable method of all. For a 12 h dissolution profile, characterized by low burst effect and drug release close to 100% at the 12th hour, sample RL_TT was the most suitable.
650    _2
$a antikonvulziva $x aplikace a dávkování $x chemie $7 D000927
650    _2
$a celulosa $x chemie $7 D002482
650    _2
$a léky s prodlouženým účinkem $x chemie $7 D003692
650    _2
$a příprava léků $x metody $7 D004339
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a deriváty hypromelózy $x chemie $7 D065347
650    _2
$a multivariační analýza $7 D015999
650    _2
$a piracetam $x aplikace a dávkování $x analogy a deriváty $x chemie $7 D010889
650    _2
$a kyseliny polymethakrylové $x chemie $7 D011109
650    _2
$a rozpustnost $7 D012995
650    _2
$a tablety $7 D013607
650    _2
$a teplota $7 D013696
655    _2
$a časopisecké články $7 D016428
700    1_
$a Peček, Daniel $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Hasserová, Kristýna $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Doležel, Petr $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Pavelková, Miroslava $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Vyslouzil, Jakub $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Muselík, Jan $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
700    1_
$a Vetchy, David $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
773    0_
$w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 22, č. 2 (2017), s. 206-217
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28058866 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427100500 $b ABA008
999    __
$a ok $b bmc $g 1199779 $s 974092
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 22 $c 2 $d 206-217 $e 20170106 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...